Teladoc Health reviews

Stock is just stuck for some reason

Teladoc operates in a state of constant upheaval. What began as annual reorganizations and layoffs in 2023 escalated to three rounds in just the first half of 2025. Leadership turnover is high, and each new team brings a fresh—yet equally unclear—strategy that rarely lasts. Middle management tends to echo corporate messaging without addressing real concerns. Feedback is routinely dismissed, and decisions are made top-down with little transparency or input from the teams doing the work. My local team suffered under a micromanaging and ineffective manager. Despite repeated feedback to HR and senior leadership, nothing changed—highlighting a culture where poor management is tolerated rather than corrected. International teams were especially affected by abrupt strategic shifts. After years of building global hubs, leadership suddenly deprioritized them, leaving entire teams blindsided and unsupported.